Artificial Intelligence in Prostate Cancer Diagnosis on Magnetic Resonance Imaging: Time for a New PARADIGM.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 40312251.
- Also identified by DOI 10.1016/j.eururo.2025.04.018.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Artificial intelligence (AI) may provide a solution for improving access to expert, timely, and accurate magnetic resonance imaging (MRI) interpretation. The PARADIGM trial will provide level 1 evidence on the role of AI in the diagnosis of prostate cancer on MRI.
Medical subject headings
- Prostatic Neoplasms
- Artificial Intelligence
- Magnetic Resonance Imaging